Leishmaniasis in IBD Patients: Challenges of a Rare Opportunistic Disease.

United European Gastroenterol J

Serviço de Doenças Infeciosas, Hospital de São joão, Unidade Local de Saúde de São João, Porto, Portugal.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188327PMC
http://dx.doi.org/10.1002/ueg2.12753DOI Listing

Publication Analysis

Top Keywords

leishmaniasis ibd
4
ibd patients
4
patients challenges
4
challenges rare
4
rare opportunistic
4
opportunistic disease
4
leishmaniasis
1
patients
1
challenges
1
rare
1

Similar Publications

Examining miR-196a, miR-196b and NF-κBIα gene expression in colitis mice model.

AMB Express

July 2025

Department of Parasitology and Mycology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Bifidobacterium bifidum (B. bifidum) anti-inflammatory characteristics and ability to modify the gut microbiota make it a promising treatment option for Inflammatory Bowel Disease (IBD). The present study investigated the modulatory effects of B.

View Article and Find Full Text PDF

Leishmaniasis in IBD Patients: Challenges of a Rare Opportunistic Disease.

United European Gastroenterol J

June 2025

Serviço de Doenças Infeciosas, Hospital de São joão, Unidade Local de Saúde de São João, Porto, Portugal.

View Article and Find Full Text PDF

Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU.

United European Gastroenterol J

June 2025

Gastroenterology Department, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital General Universitario Dr Balmis de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Madrid, Spain.

Background: Leishmaniasis (LI) is a vector-borne illness caused by a protozoan of the genus Leishmania. Data on the features of LI in patients with inflammatory bowel disease (IBD) are scarce.

Aim: To describe the characteristics of patients with IBD who present with leishmaniasis, infection outcomes and the risk factors associated with developing visceral leishmaniasis (VL).

View Article and Find Full Text PDF
Article Synopsis
  • * The study examined the effects of D. dendriticum egg antigen on mice with colitis induced by DSS, using various measures to evaluate the condition's severity and immune response.
  • * Results showed that D. dendriticum egg antigen notably improved colitis symptoms, enhanced the expression of beneficial cytokines, and reduced inflammatory markers, indicating its potential as a treatment for ulcerative colitis.
View Article and Find Full Text PDF

Infection by Leishmania spp. in patients diagnosed with inflammatory bowel disease (IBD) is rare. Considered endemic in the Mediterranean basin, its manifestations are almost exclusive of patients with impaired cellular immunity.

View Article and Find Full Text PDF